Surprisingly, however, genetic activation of Nrf2 has been reported to increase steatosis and inflammation in both leptin-deficient and HF-fed animals (46, 47), and it has been speculated that Keap1 may influence NASH by uncharacterized mechanisms that do not involve Nrf2. Here, KEAP1 is linked to metabolic dysfunction-associated steatohepatitis.